<code id='F4F4D29C5C'></code><style id='F4F4D29C5C'></style>
    • <acronym id='F4F4D29C5C'></acronym>
      <center id='F4F4D29C5C'><center id='F4F4D29C5C'><tfoot id='F4F4D29C5C'></tfoot></center><abbr id='F4F4D29C5C'><dir id='F4F4D29C5C'><tfoot id='F4F4D29C5C'></tfoot><noframes id='F4F4D29C5C'>

    • <optgroup id='F4F4D29C5C'><strike id='F4F4D29C5C'><sup id='F4F4D29C5C'></sup></strike><code id='F4F4D29C5C'></code></optgroup>
        1. <b id='F4F4D29C5C'><label id='F4F4D29C5C'><select id='F4F4D29C5C'><dt id='F4F4D29C5C'><span id='F4F4D29C5C'></span></dt></select></label></b><u id='F4F4D29C5C'></u>
          <i id='F4F4D29C5C'><strike id='F4F4D29C5C'><tt id='F4F4D29C5C'><pre id='F4F4D29C5C'></pre></tt></strike></i>

          comprehensive

          comprehensive

          author:Wikipedia    Page View:9
          the shape of a medical note connected by dots and lines — health tech coverage from STAT
          Adobe

          In recent months, the federal government has repeatedly told Medicare Advantage insurers that they cannot use artificial intelligence or algorithms to deny medical services the government routinely covers.

          But in finalizing a rule to that effect, it also stepped into a thicket of questions from insurers about a technology that is especially difficult to pin down: What is AI? Can it be used at all to make decisions about the coverage of older patients? If so, how?

          advertisement

          This week, the federal agency that oversees Medicare sought to boil it all down into a simple directive: Put the circumstances of the individual patient first, and your algorithm second.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies
          Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

          AdobeSometimes,anappleadayreallyisjustwhatthedoctorordered.Andforthepastseveralyears,organizationsli

          read more
          Gene therapies for deafness raise the question: Do deaf people want a 'cure'?
          Gene therapies for deafness raise the question: Do deaf people want a 'cure'?

          Advancesingenetherapycouldeventually"cure"manyformsofcongenitaldeafness.Thechangeshavemanydeafpeople

          read more
          Duchenne breakthrough therapy leaves behind pioneering families
          Duchenne breakthrough therapy leaves behind pioneering families

          DuchennemusculardystrophyDr.EdwinP.Ewing,Jr./CDCPatFurlongwassittinginherhomeofficeinMiddletown,Ohio

          read more

          Lab trade group sues FDA to halt regulation of lab

          Thesuit,filedinaTexasfederalcourtbytheAmericanClinicalLaboratoryAssociationandPCRlabHealthTrackRx,cl